SEC EDGAR Filing Information

Form 8-K -- Current report

Period of Report: 2007-04-24
Filing Date Changed: 2007-04-26
Documents: 3
SEC Accession No.
0001193125-07-092094
Filing date: 2007-04-27
Accepted: 2007-04-26 19:25:44
Item 1.02: Termination of a Material Definitive Agreement
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Table of submitted documents:

Seq Type Document Size Description
1 8-K d8k.htm 13124 FORM 8-K
2 EX-99.1 dex991.htm 4402 PRESS RELEASE
3 GRAPHIC g15348logo.jpg 17741 GRAPHIC
0001193125-07-092094.txt 44415 Complete submission text file

Filer Information:

US ONCOLOGY INC (Filer) (0000943061)
IRS No.: 841213501 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-26190 | Film No.: 07792862
SIC: 8093 Services-Specialty Outpatient Facilities, NEC

  Assistant Director 1
Business Address
16825 NORTHCHASE DR
STE 1300
HOUSTON TX 77060
2818732674
 Mailing Address

US Oncology Holdings, Inc. (Filer) (0001333191)
IRS No.: 200873619 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 333-126922 | Film No.: 07792861
SIC: 8060 Services-Hospitals

  Assistant Director 1
Business Address
16825 NORTHCHASE DRIVE, SUITE 1300
HOUSTON TX 77060
(832) 601-8766
 Mailing Address
16825 NORTHCHASE DRIVE, SUITE 1300
HOUSTON TX 77060